BriaCell Therapeutics Corp. (BCTX): Capital Expenditures

Annual figures by period end, from SEC filings.

$456.8K

Year ended 2024-07-31

Period ended	Capital Expenditures	Change YoY	Source filing
2024-07-31	$456.8K	n/a	2025-10-16, From 2023-08-01